Links among genetic variants and hierarchical brain structural and functional networks for antidepressant treatment: A multivariate study

Brain Res. 2024 Jan 1:1822:148661. doi: 10.1016/j.brainres.2023.148661. Epub 2023 Nov 2.

Abstract

Background: Antidepressant treatment effects are strongly heritable and have substantial effects on brain function and structure, but the underlying mechanisms are still poorly understood. In this research, we aimed to evaluate the factors of single nucleotide polymorphisms (SNPs) and hierarchical brain structural and functional networks that were associated with antidepressant treatment. Moreover, we further explored the correlations and mediation pattern among "brain structure-brain function-gene" in major depressive disorder (MDD).

Methods: We analysed 405 SNPs and rich club/feeder/local connections of hierarchical structural and functional networks with three-way parallel independent component analysis in 179 MDD patients. The group-discriminative independent components of the three modalities between responders and non-responders of antidepressant treatment were identified. Pearson correlations and mediation analysis were further utilized to investigate the associations among SNPs and connections of the structural and functional networks.

Results: Notably, correlations with antidepressant treatment outcomes were found in structural, functional and SNP modalities simultaneously. The features of group-discriminative independent components included the shared feeder connections of hub regions with the inferior frontal orbital gyrus and amygdala in structural and functional modalities and genes enriched in circadian rhythmic processes and dopaminergic synapse pathways. The structural feeder network displayed close correlations with SNPs and the functional feeder network. Furthermore, the structural feeder network could mediate the association between SNPs and the functional feeder network, implying that genetic variants might influence brain function by affecting brain structure in MDD.

Conclusions: These findings provide potential biomarkers for antidepressant therapy and provide a better grasp of the associations among SNPs and hierarchical structural and functional networks in MDD.

Keywords: Antidepressant treatment; Diffusion tensor imaging; Functional magnetic resonance imaging; Multimodal fusion; Single-nucleotide polymorphism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antidepressive Agents / therapeutic use
  • Brain
  • Depressive Disorder, Major* / drug therapy
  • Depressive Disorder, Major* / genetics
  • Diffusion Tensor Imaging
  • Humans
  • Magnetic Resonance Imaging
  • Prefrontal Cortex

Substances

  • Antidepressive Agents